Highlights and Accomplishments
Sickle Cell Volumes
- The Aflac Cancer Center has the largest pediatric sickle cell program in the country, treating more than 1,600 children with the disease.
- To date, the Aflac Cancer Center has treated more than 30 children with sickle cell disease through matched-sibling blood and marrow transplants (BMTs)—with a 96 percent disease-free survival rate.
Sickle Cell Program Highlights
- With outcomes exceeding the national average, the Aflac Cancer Center has performed more blood and marrow transplants (BMTs) for sickle cell disease than any other program in the country. This includes the first successful unrelated cord blood transplant for sickle cell disease and the greatest number of matched related transplants performed nationwide.
- Medical research, including work done at the Aflac Cancer Center, has greatly improved treatment for children and adults with sickle cell disease. Together with other national experts and treatment centers nationwide, clinical research trials are currently being administered at the Aflac Cancer Center, with a focus on improving the quality of life and reducing the complications for children affected by this disease.
- The Aflac Cancer Center is one of only eight centers in the United States awarded funds to participate in a National Institutes of Health (NIH) clinical research network.Peter Lane, M.D., was the first chair of the national network, which conducts multicenter trials to improve the treatment and outcomes of children and adults with sickle cell disease.
- The Aflac Cancer Center is a member of theAtlanta Sickle Cell Consortium—a citywide effort that includes physicians and researchers from Children’s, Grady Health System, Emory University and Morehouse schools of medicine, Emory’s Winship Cancer Institute and Georgia Tech. The members of the Atlanta Sickle Cell Consortium are conducting research to advance the treatment of sickle cell disease and to find a cure for the disease.
Physician Leadership Impact
- Aflac Cancer Center and Blood Disorders Service physicians and staff have national leadership positions in more than 18 different organizations, including the National Sickle Cell Clinical Research Network.